¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"negative stranded RNA virus"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • enteric cytopathogenic human orphan virus
    ¿¡ÄÚ¹ÙÀÌ·¯½º
  • enveloped virus
    ²®Áúº¸À¯¹ÙÀÌ·¯½º, ¿ÜÇǺ¸À¯¹ÙÀÌ·¯½º
  • epidemic gastroenteritis virus
    À¯ÇàÀ§Àå¿°¹ÙÀÌ·¯½º
  • Epstein-Barr virus
    ¿¦½ºÅ¸ÀÎ-¹Ù¹ÙÀÌ·¯½º
  • foamy virus
    °ÅǰÇü¼º¹ÙÀÌ·¯½º
  • helper virus
    º¸Á¶¹ÙÀÌ·¯½º
  • hemadsorption virus
    Ç÷±¸ÈíÂø¹ÙÀÌ·¯½º
  • hepatitis E virus
    EÇü°£¿°¹ÙÀÌ·¯½º
  • hepatitis G virus
    GÇü°£¿°¹ÙÀÌ·¯½º
  • herpes simplex virus
    ´Ü¼øÇ츣Æä½º¹ÙÀÌ·¯½º
  • human immunodeficiency virus
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
  • human immunodeficiency virus-2
    »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º2
  • human papilloma virus
    »ç¶÷À¯µÎÁ¾¹ÙÀÌ·¯½º
  • human papilloma virus test
    »ç¶÷À¯µÎÁ¾¹ÙÀÌ·¯½º°Ë»ç
  • human T-cell lymphoma/leukemic virus
    »ç¶÷T¼¼Æ÷¸²ÇÁÁ¾/¹éÇ÷º´¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • negative electricity
    À½Àü±â
  • negative electrode
    À½±Ø
  • false-negative
    °ÅÁþÀ½¼º
  • false negative reaction
    °ÅÁþÀ½¼º¹ÝÀÀ
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • negative feeling
    ºÎÁ¤Àû°¨Á¤
  • gram-negative
    ±×¶÷À½¼º-
  • gram negative shock
    ±×·¥À½¼º¼îÅ©
  • negative inotropic
    °¨¼Ò¼öÃà·Â
  • negative ion
    À½ÀÌ¿Â
  • lower body negative pressure
    ÇÏüÀ½¾Ð
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü
  • negative field method
    ºÎÁ¤Á¶»ç¿µ¿ª¹ý
  • negative staining method
    À½¼º¿°»ö¹ý
  • negative
    ¿ª-, ºÎÁ¤Àû-, À½¼º-
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Cremean hemorrhagic fever virus
    Å©¸®¹Ì¾Æ ÃâÇ÷¿­¹ÙÀÌ·¯½º
  • DNA oncogenic virus
    DNA Á¾¾ç¹ÙÀÌ·¯½º
  • DNA virus
    DNA¹ÙÀÌ·¯½º
  • DNA oncogenic virus
    DNA Á¾¾ç¹ÙÀÌ·¯½º
  • DNA virus
    DNA ¹ÙÀÌ·¯½º
  • DNA-containing virus
    DNA(Æ÷ÇÔ)¹ÙÀÌ·¯½º.
  • Dengue virus
    µ­±â ¹ÙÀÌ·¯½º
  • EB virus
    EB¹ÙÀÌ·¯½º
  • ECHO virus =enteric cytopathogenic dog or p han v.
    ¿¡ÄÚ¹ÙÀÌ·¯½º.
  • ECHO virus =enteric cytopathogenic human orphan v.
    ¿¡ÄÚ¹ÙÀÌ·¯½º(¼Ó).
  • ECHO virus infection
    ¿¡ÄÚ¹ÙÀÌ·¯½º°¨¿°.
  • ECHO virus infection
    ¿¡ÄÚ¹ÙÀÌ·¯½º°¨¿°.
  • Eastern equine encephalitis virus
    µ¿ºÎ¸»³ú¿°¹ÙÀÌ·¯½º
  • Eastern equine encephalitis virus
    µ¿ºÎ ¸» ³ú¿° ¹ÙÀÌ·¯½º
  • Ebola virus
    ¿¡º¼¶ó¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • negative declination
    ³»È¸¼±
  • negative dromotropy
    (½É)º¯Á¶°¨¼Ò(ÀÛ¿ë).
  • negative electricity
    À½Àü±â(ëäï³Ñ¨).
  • negative electrode
    À½±Ø(ëäп).
  • negative electron
    À½ÀüÀÚ
  • negative entropy
    À½¿£Æ®·ÎÇÇ.
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • negative feedback inhibition
    À½¼ºµÇ¸ÔÀÓ¾ïÁ¦.
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü.
  • negative feeling
  • negative field method
    ºÎÁ¤Á¶»ç¿µ¿ª¹ý
  • negative inotropic
    ¼öÃà·Â°¨¼Ò¼ºÀÇ
  • negative ion
    À½(ëä)ÀÌ¿Â.
  • negative nitrogen balance
    À½¼ºÁú¼ÒÆòÇü (~òòáÈøÁû¬), ¼Ò½Ç¼º Áú¼Ò
  • negative phase
    À½¼º±â(ëäàõÑ¢), À½¼º»ó(ëäàõßÓ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • acceptor RNA
    ¼ö¿ë(â¥é»)RNA
  • adapter RNA
    ¾Æ´äÅÍ RNA
  • adaptor RNA
    ¾Æ´äÅÍ RNA
  • amino acid accepting RNA
    ¾Æ¹Ì³ë»ê(ß«) ¼ö³³(áôÒ¡)RNA
  • chromosomal RNA
    ¿°»öü(æøßäô÷) RNA
  • complementary RNA
    »óº¸¼º(ßÓÜÍàõ) RNA
  • complex RNA
    º¹ÇÕ(ÜÜùê) RNA
  • DNA-dependent RNA polymerase
    DNAÀÇÁ¸ RNA Æú¸®¸Ó·¹À̽º
  • DNA-like RNA
    DNAÀ¯»ç(×¾ÞÄ) RNA
  • DNA-RNA hybrid
    DNA-RNA Æ¢±â
  • early RNA
    Á¶±â(ðÄÑ¢) RNA
  • giant messenger-like RNA
    °Å´ë(ËÝÓÞ) À¯»çÀü·É(×¾ÞÄîîÖµ) RNA
  • giant RNA
    °Å´ë(ËÝÓÞ) RNA
  • heterogeneous nuclear RNA
    ÀÌÁú(ì¶òõ) ÇÙ(ú·)RNA
  • immediate early RNA
    ÃÖÁ¶±â(õÌðÄÑ¢) RNA
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ALV Abelson leukemia virus; adeno-like virus; alveolar, alveolus; ascending lumbar vein; avian leukosis ...
RV random variable; rat virus; Rauscher virus; rectovaginal; reinforcement value; renal vein; residual ...
SV saphenous vein; sarcoma virus; satellite virus; selective vagotomy; semilunar valve; seminal vesicle...
RS virus Respiratory Synthitial virus
ADV adenovirus; adventitia; Aleutian disease virus; Aujeszky disease virus
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ps Parallel-stranded
SSCP Single Stranded Conformational Polymorphism
SSCP Single Stranded Conformational Polymorphism analysis
ss Single stranded
SSCP Single stranded conformation polymorphism
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • human immunodeficiency virus infection
    Àΰ£ ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º °¨¿°
  • human papilloma virus
    ÀÎü À¯µÎÁ¾ ¹ÙÀÌ·¯½º
    ÀÎü Áúȯ°ú µ¿¹° Áúȯ°úÀÇ À¯»çÁ¡Àº ¸Å¿ì ³î¶ø´Ù. ÇǺÎÀÇ ÆíÆò »óÇÇ ¼¼Æ÷¿¡ ´ëÇÑ ÇöÀúÇÑ Ä£È­¼ºÀ» º¸ÀδÙ. µ¿¹°¿¡¼­ À¯µÎÁ¾ ¹ÙÀÌ·¯½º´Â ÆíÆò »óÇÇ¿¡ ¾ç¼º À¯µÎÁ¾, ÀåÀÇ ¼± »óÇÇ¿¡ ¼±Á¾, ¹æ±¤¿¡ À¯µÎÁ¾À» ÀÏÀ¸Å°¸ç »ó´çÇÑ ¼ö°¡ ¾Ç¼ºÀ¸·Î ÁøÇàµÈ´Ù. »ç¶÷¿¡¼­µµ ÈĵÎÀÇ À¯µÎÁ¾, ¿ÜÀ½, À½°æ, Ç×¹® ÁÖº¯ºÎ¿¡ ÷±Ô Äܵô·Ò
  • human T cell leukemia virus type II
    Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • human t-cell leukemia virus
    ÀÎü T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • infectious hepatitis virus
    Àü¿°¼º °£¿° ¹ÙÀÌ·¯½º
  • Japanese encephalitis virus
    ÀϺ» ³ú¿° ¹ÙÀÌ·¯½º
    ÀϺ» ³ú¿°ÀÇ º´¿øÃ¼. 1934³â¿¡ ÇϾ߽ð¡ ³ú³» Á¢Á¾¹ý¿¡ ÀÇÇØ óÀ½ ¿ø¼þÀÌ¿¡°Ô ÀüÆÄÇϰí, 36³â¿¡´Â ´Ù´Ï±¸Ä¡, °¡»çÇ϶ó µîÀÌ ½ÇÇè¿ë Á㸦 ÀÌ¿ëÇÏ¿© ºÐ¸®¿¡ ¼º°øÇÏ¿´´Ù. Å©±â´Â 15¡­30 mÀÌ°í ¼¼ÀÎÆ®·çÀ̽º ³ú¿°À̳ª ¼­ ³ªÀÏ ³ú¿°ÀÇ ¹ÙÀÌ·¯½º¿Í ºñ½ÁÇѵ¥, º´µ¶ÀÇ ÁßÈ­ ½ÃÇèÀ¸·Î ±¸º°ÇÑ´Ù. ¸ð±â°¡ ¸Å°³ÇÏ¿© »ç¶÷°ú °¡Ãà¿¡ °¨¿°µÇ´Âµ¥, ¸ð±â°¡ ¾ø´Â µ¿°è¸¦ ¾î¶»°Ô ³Ñ±â°í ´ÙÀ½ÇØ¿¡ ´Ù½Ã À¯ÇàÇÏ´ÂÁö ÆÇ¸íµÇ¸é ¿¹¹æ ´ëÃ¥ÀÌ È®¸³µÇ´Â °ÍÀ̳ª ¾ÆÁ÷ ¹àÇôÁöÁö ¾Ê°í ÀÖ´Ù. ¿Â´ëÁö¹æ¿¡¼­´Â µ¿¸éÇÑ ¸ð±âÀÇ Ã¼³»¿¡¼­ ÇØ¸¦ ³Ñ±æ °¡´É¼ºµµ ÀÖÀ¸³ª ¾ÆÁ÷ ÀÔÁõµÇÁö ¾Ê¾Ò°í, ¸ð±â¸¦ Àâ¾Æ¸Ô´Â µµ¸¶¹ìÀ̳ª µµ¸¶¹ìºÙÀÌÀÇ Ã¼³»¿¡¼­ ÇØ¸¦ ³Ñ±æ °¡´É¼ºÀ̳ª, µÕÁö¸¦ ¶°³¯ ¼ö ¾ø´Â µé»õ, ƯÈ÷ ±îÄ¡·ùÀÇ Ã¼³»¿¡¼­ »ì¾Æ³²´Â´Ù´Â °ßÇØµµ ÀÖ´Ù. ÇÑÆí °¨¿°µÈ ¸»À̳ª µÅÁö´Â ±× ÇØÀÇ ¹ÙÀÌ·¯½º¸¦ ¼ºÀå½Ãų ¼ö´Â ÀÖÀ¸³ª ¹ÙÀÌ·¯½ºÀÇ º¸À¯ µ¿¹°Àº ¾Æ´Ï¶ó°í ÇÑ´Ù.
  • Lassa fever virus
    ¶ó»ç ¿­ ¹ÙÀÌ·¯½º
    ¾Æ·¹³ª ¹ÙÀÌ·¯½º°ú¿¡ ¼ÓÇÏ¸ç ¼­¾ÆÇÁ¸®Ä«¿¡ »ç´Â ¾ÆÇÁ¸®Ä« ÁýÁã »çÀÌ¿¡ Áö¼Ó °¨¿°µÇ°í ÀÖÀ¸¸ç »ç¶÷¿¡ ´ëÇÑ °¨¿°Àº Ÿ¾×À̳ª ´¢Áß¿¡ ¹è¼³µÈ ¹ÙÀÌ·¯½º¿¡ ¿À¿°µÈ À½½Ä¹°À̳ª ½Ä±â¸¦ ÅëÇØ¼­ ÀϾ´Ù.
  • lymphadenopathy virus
    ¸²ÇÁÀýÁõ ¹ÙÀÌ·¯½º
  • lymphocystis virus
    ÀÓÆÄ ³¶Á¾ ¹ÙÀÌ·¯½º
  • measles virus
    È«¿ª ¹ÙÀÌ·¯½º
    ÆÄ¶ó ¹Í¼Ò ¹ÙÀÌ·¯½ºÀÇ ÀϹÝÀû ¼º»óÀ» Áö´Ñ º´¿øÃ¼·Î, »ç¶÷°ú ¿ø¼þÀÌ¿¡ º´¿ø¼ºÀ» ³ªÅ¸³½´Ù. RNA ¹ÙÀÌ·¯½º·Î 56¡É¿¡¼­ 30ºÐ °¡¿­ÇÏ¸é ºÒȰ¼ºÈ­µÈ´Ù. È«¿ª ȯÀÚÀÇ Ä§, °¡·¡, ¿ÀÁÜ¿¡ ÀÖ´Ù. È«¿ª ¹ÙÀÌ·¯½º°¡ Á¸ÀçÇÏ¸é ¸²ÇÁ±¸ Áõ°¡¿Í ¹éÇ÷±¸ °¨¼Ò°¡ º¸ÀÌ°í ¸²ÇÁÀý, Æíµµ¼± µî¿¡´Â ´ÙÇÙ ¼¼Æ÷°¡ ³ªÅ¸³­´Ù
  • monkey pox virus
    ¿ø¼þÀÌ Æø½º ¹ÙÀÌ·¯½º
  • neonatal calf diarrhea corona virus
    ½Å»ý¾Æ ¼³»ç Äڷγª ¹ÙÀÌ·¯½º
  • neurotropic virus
    Çâ½Å°æ¼º ¹ÙÀÌ·¯½º
  • oral herpes simplex virus
    ±¸°­ ´Ü¼ø Æ÷Áø ¹ÙÀÌ·¯½º
  • papilloma virus
    À¯µÎÁ¾ ¹ÙÀÌ·¯½º
    Àΰ£°ú µ¿¹°¿¡¼­ À¯µÎÁ¾ ¶Ç´Â »ç¸¶±Í¸¦ ÀÏÀ¸Å°´Â ¹ÙÀÌ·¯½ºÀÇ ¹«¸®. ÆÄº¸¹Ù ¹ÙÀÌ·¯½º°ú¿¡ ¼ÓÇÑ´Ù. º´ÀÇ ÀüÆÄ´Â º¸Åë ȯÀÚ¿ÍÀÇ Á÷Á¢ Á¢ÃËÀ̳ª ÀÚ°¡ Á¢Á¾¿¡ ÀÇÇÑ´Ù. »ç¸¶±Í´Â ÀϹÝÀûÀ¸·Î ÀÚÀ²¼º º´º¯À¸·Î 6°³¿ù ³»Áö 2³â ³»¿¡ ÀÚ¿¬ ¼Ò½ÇµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
lens, negative <microscopy> A lens that is thicker on the edges than in the centre, and which causes parallel light rays to diverge.
Synonym: diverging lens.
(05 Aug 1998)
lower body negative pressure External decompression applied to the lower body. It is used to study orthostatic intolerance and the effects of gravitation and acceleration, to produce simulated haemorrhage in physiologic research, to assess cardiovascular function, and to reduce abdominal stress during childbirth.
(12 Dec 1998)
bovine virus diarrhoea virus A virus of the genus Pestivirus, in the family Togaviridae, causing bovine virus diarrhoea; New York, Oregon, and Indiana strains of the virus are recognised.
Synonym: mucosal disease virus.
(05 Mar 2000)
acceptor RNA rNA
antisense RNA <molecular biology> A complementary RNA sequence that binds to (and thus blocks the transcription of) a naturally-occuring (sense) messenger RNA molecule.
These proteins can be used to selectively turn off production of certain proteins or block viral genetic instructions, by marking them for destruction by cellular enzymes, in order to prevent the building of new virus or the infection of new cells.
(09 Oct 1997)
bacteriophage T3 RNA polymerase <enzyme> Used for the rapid generation of strand-specific RNA molecules that can be used for the identification of genes in hybridization experiments
Registry number: EC 2.7.7.-
Synonym: t3 RNA polymerase
(26 Jun 1999)
cap II RNA(nucleoside-2'-)methyltransferase <enzyme> Converts cap i-terminated mRNA to cap II-terminated mRNA
Registry number: EC 2.1.1.-
Synonym: cap II methylase
(26 Jun 1999)
cap I RNA (nucleoside-2'-)methyltransferase <enzyme> Converts cap 0-terminated mRNA to cap i-terminated mRNA
Registry number: EC 2.1.1.-
Synonym: cap I methylase
(26 Jun 1999)
p68 RNA helicase <enzyme> An RNA helicase isolated from uv-induced tumours in mice; amino acid sequence has been determined
Registry number: EC 2.7.7.-
Synonym: dead box helicase p68
(26 Jun 1999)
masked messenger RNA <molecular biology> Long lived and stable mRNA found originally in the oocytes of echinoderms and constituting a store of maternal information for protein synthesis that is unmasked (derepressed) during the early stages of morphogenesis.
In these early stages the rate of cell division is so rapid that transcription from the embryonic genome cannot occur. Undoubtedly not restricted to oocytes and the term can be applied to any mRNA which is present in inactive form.
(18 Nov 1997)
ribosomal RNA <molecular biology> A nucleic acid found in all living cells. Plays a role in transferring information from DNA to the protein-forming system of the cell.
(16 Dec 1997)
messenger-like RNA An ill-defined form of RNA, of high molecular weight, that never leaves the nucleus and is thought to be the precursor of messenger RNA.
(05 Mar 2000)
messenger RNA <molecular biology> Single stranded RNA molecule that specifies the amino acid sequence of one or more polypeptide chains. This information is translated during protein synthesis when ribosomes bind to the mRNA.
In prokaryotes, mRNA is normally formed by splicing a large primary transcript from a DNA sequence and protein synthesis starts while the mRNA is still being synthesised. Prokaryote mRNAs are usually very short lived (average t 1/2 is 5mins.).
In contrast, in eukaryotes the primary transcripts (HnRNA) are synthesised in the nucleus and they are extensively processed to give the mRNA that is exported to the cytoplasm where protein synthesis takes place.
This processing includes the addition of a 5' 5' linked 7 methyl guanylate cap at the 5' end and a sequence of adenylate groups at the 3' end, the poly A tail, as well as the removal of any introns and the splicing together of exons, only 10% of HnRNA leaves the nucleus.
Eukaryote mRNAs are comparatively long lived with a half life ranging from 30minutes to 24 hours.
(27 Jun 1999)
GTP-RNA guanylyltransferase <enzyme> Catalyses addition of GMP residue to 3'-ends of oligonucleotide primers
Registry number: EC 2.7.7.-
Synonym: terminal guanylyltransferase
(26 Jun 1999)
RNA <molecular biology> A nucleic acid found in all living cells. Plays a role in transferring information from DNA to the protein-forming system of the cell.
(16 Dec 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á